These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 14696137

  • 1. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS, Luckasevic TM, Noga CM, Johnson DR, Silverman JF, Liu YL.
    Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137
    [Abstract] [Full Text] [Related]

  • 2. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
    Ahuja A, Gupta N, Kalra N, Srinivasan R, Chawla Y, Rajwanshi A.
    Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the CD34 and CD10 immunostains using a two-color staining protocol in liver fine-needle aspiration biopsies.
    Zimmerman RL, Logani S, Baloch Z.
    Diagn Cytopathol; 2005 Feb; 32(2):88-91. PubMed ID: 15637673
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F, Abdallah H, Meschter S.
    Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758
    [Abstract] [Full Text] [Related]

  • 5. The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma.
    Karabork A, Kaygusuz G, Ekinci C.
    Pathol Res Pract; 2010 Aug 15; 206(8):572-7. PubMed ID: 20400233
    [Abstract] [Full Text] [Related]

  • 6. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
    Wang L, Vuolo M, Suhrland MJ, Schlesinger K.
    Acta Cytol; 2006 Aug 15; 50(3):257-62. PubMed ID: 16780018
    [Abstract] [Full Text] [Related]

  • 7. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
    Röcken C, Licht J, Roessner A, Carl-McGrath S.
    J Clin Pathol; 2005 Oct 15; 58(10):1069-75. PubMed ID: 16189153
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C, Marsh W, Frankel WL.
    Mod Pathol; 2002 Dec 15; 15(12):1279-87. PubMed ID: 12481008
    [Abstract] [Full Text] [Related]

  • 11. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
    Saleh HA, Aulicino M, Zaidi SY, Khan AZ, Masood S.
    Diagn Cytopathol; 2009 Mar 15; 37(3):184-90. PubMed ID: 19170172
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Polyclonal carcinoembryonic antigen staining in the cytologic differential diagnosis of primary and metastatic hepatic malignancies.
    Wolber RA, Greene CA, Dupuis BA.
    Acta Cytol; 1991 Mar 15; 35(2):215-20. PubMed ID: 1709323
    [Abstract] [Full Text] [Related]

  • 14. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
    Foschini MP, Macchia S, Baccarini P, Milandri GL, Losi L, Spongano P, Panarelli M, Dal Monte PR, Eusebi V.
    Pathologica; 1999 Aug 15; 91(4):260-7. PubMed ID: 10630075
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM, Loera S, Lau SK, Ishizawa S, Jiang Z, Wu CL, Yen Y, Weiss LM, Chu PG.
    Am J Surg Pathol; 2008 Mar 15; 32(3):433-44. PubMed ID: 18300806
    [Abstract] [Full Text] [Related]

  • 17. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK, Prakash S, Geller SA, Alsabeh R.
    Hum Pathol; 2002 Dec 15; 33(12):1175-81. PubMed ID: 12514785
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic utility of CD10 immunohistochemical staining on cellblock in differentiating hepatocellular carcinoma from secondary malignancies of liver.
    Singha J, Khan K, Chatterjee S.
    Indian J Pathol Microbiol; 2018 Dec 15; 61(4):510-515. PubMed ID: 30303139
    [Abstract] [Full Text] [Related]

  • 20. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A, Cohen C, Siddiqui MT.
    Diagn Cytopathol; 2009 Sep 15; 37(9):629-35. PubMed ID: 19405109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.